Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

Reports
Global Markets Direct’s wide variety of reports offer a targeted solution for marketing and strategic planning. These reports include in-depth company reports such as Company Market Share reports, which give a detailed breakdown of revenues by market and region, and Company Asset Reports, which give details of companies’ key assets by geography.
Company Strategic Analysis Reports include in-depth value chain and SWOT analysis, while Company Financial Deal Profiles highlight key financial deals that have shaped the company. Global Markets Direct also produces a wide range of market reports giving access to high value unique databases of information, examples include historic and forecast asset reports and market share reports covering value, volume, distribution and company shares.

Sectors and Geographies Covered
Global Markets Direct specializes in the Energy and Medical Equipment Markets. It has a global scope, covering a broad range of countries constituting more than 90% of global revenues in each of the industries it covers.

Research Methodology
With a large dedicated research and analysis capability, Global Markets Direct employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.

Global Markets Direct
 

List of reports from Global Markets Direct

< prev 5  6  7  8  9  10  11  12  13  14  next >
Egypt Endoscopy Devices Investment Opportunities, Analysis and Forecasts to 2017
3/19/2012 | published by: Global Markets Direct
... Endoscopy Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – Capsule Endoscope Systems, Endoscopic Instruments, Endoscopic Reprocessors, Endoscopy Fluid ...  |  more...
$2,500.00
Ireland Surgical Equipment Investment Opportunities, Analysis and Forecasts to 2018
3/19/2012 | published by: Global Markets Direct
... Surgical Equipment market. The report provides value (USD million), volume (units) and average price (USD) data for each segment within three market categories – Electrosurgical Devices, Hand Instruments and Surgical Sutures. The report also provides ...  |  more...
$2,500.00
Greece Surgical Equipment Investment Opportunities, Analysis and Forecasts to 2018
3/19/2012 | published by: Global Markets Direct
... Surgical Equipment market. The report provides value (USD million), volume (units) and average price (USD) data for each segment within three market categories – Electrosurgical Devices, Hand Instruments and Surgical Sutures. The report also provides ...  |  more...
$2,500.00
Portugal Surgical Equipment Investment Opportunities, Analysis and Forecasts to 2018
3/19/2012 | published by: Global Markets Direct
... Surgical Equipment market. The report provides value (USD million), volume (units) and average price (USD) data for each segment within three market categories – Electrosurgical Devices, Hand Instruments and Surgical Sutures. The report also provides ...  |  more...
$2,500.00
Turkey Surgical Equipment Investment Opportunities, Analysis and Forecasts to 2018
3/19/2012 | published by: Global Markets Direct
... Surgical Equipment market. The report provides value (USD million), volume (units) and average price (USD) data for each segment within three market categories – Electrosurgical Devices, Hand Instruments and Surgical Sutures. The report also provides ...  |  more...
$2,500.00
Egypt Surgical Equipment Investment Opportunities, Analysis and Forecasts to 2018
3/19/2012 | published by: Global Markets Direct
... Surgical Equipment market. The report provides value (USD million), volume (units) and average price (USD) data for each segment within three market categories – Electrosurgical Devices, Hand Instruments and Surgical Sutures. The report also provides ...  |  more...
$2,500.00
United Arab Emirates Surgical Equipment Investment Opportunities, Analysis and Forecasts to 2018
3/19/2012 | published by: Global Markets Direct
... data on the United Arab Emirates Surgical Equipment market. The report provides value (USD million), volume (units) and average price (USD) data for each segment within three market categories – Electrosurgical Devices, Hand Instruments and ...  |  more...
$2,500.00
Oral Mucositis – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... for Oral Mucositis , complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Oral Mucositis . 'Oral Mucositis - Pipeline Review, ...  |  more...
$500.00
Hepatitis A – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... for Hepatitis A, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hepatitis A. 'Hepatitis A - Pipeline Review, H1 2012' ...  |  more...
$500.00
Restless Legs Syndrome – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... the therapeutic development for Restless Legs Syndrome, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Restless Legs Syndrome. 'Restless Legs ...  |  more...
$500.00
Hyperoxaluria – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hyperoxaluria. 'Hyperoxaluria - Pipeline Review, H1 2012' is built using data and information ...  |  more...
$500.00
Neutropenia – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Neutropenia. 'Neutropenia - Pipeline Review, H1 2012' is built using data and information ...  |  more...
$500.00
Brain Hemorrhage – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... for Brain Hemorrhage, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Brain Hemorrhage. 'Brain Hemorrhage - Pipeline Review, H1 2012' ...  |  more...
$500.00
H1N1 Infection – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... for H1N1 Infection, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for H1N1 Infection. 'H1N1 Infection - Pipeline Review, H1 2012' ...  |  more...
$500.00
Von Willebrand Disease – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... the therapeutic development for Von Willebrand Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Von Willebrand Disease. 'Von Willebrand ...  |  more...
$500.00
Dystonia – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Dystonia. 'Dystonia - Pipeline Review, H1 2012' is built using data and information ...  |  more...
$500.00
Cervical Dysplasia – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... for Cervical Dysplasia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cervical Dysplasia. 'Cervical Dysplasia - Pipeline Review, H1 2012' ...  |  more...
$500.00
Diabetic Hypertension – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... for Diabetic Hypertension, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Diabetic Hypertension. 'Diabetic Hypertension - Pipeline Review, H1 2012' ...  |  more...
$500.00
Polycythemia Vera – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... for Polycythemia Vera, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Polycythemia Vera. 'Polycythemia Vera - Pipeline Review, H1 2012' ...  |  more...
$500.00
Acute Respiratory Distress Syndrome – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... provides information on the therapeutic development for Acute Respiratory Distress Syndrome, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acute ...  |  more...
$500.00
Hyperparathyroidism – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hyperparathyroidism. 'Hyperparathyroidism - Pipeline Review, H1 2012' is built using data and information ...  |  more...
$500.00
Peripheral Neuropathy (Sensory Neuropathy) – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... provides information on the therapeutic development for Peripheral Neuropathy (Sensory Neuropathy), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Peripheral ...  |  more...
$500.00
Uveitis – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Uveitis . 'Uveitis - Pipeline Review, H1 2012' is built using data ...  |  more...
$500.00
Critical Limb Ischemia – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... the therapeutic development for Critical Limb Ischemia , complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Critical Limb Ischemia . ...  |  more...
$500.00
Cystoid Macular Edema – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... the therapeutic development for Cystoid Macular Edema, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cystoid Macular Edema. 'Cystoid Macular ...  |  more...
$500.00
< prev 5  6  7  8  9  10  11  12  13  14  next >